BioDelivery Sciences (BDSI) Misses Q4 EPS by 5c

BioDelivery Sciences (NASDAQ: BDSI) reported Q4 EPS of ($0.29), $0.05 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $12.5 million versus the consensus estimate of $9.77 million.

For earnings history and earnings-related data on BioDelivery Sciences (BDSI) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
• InspireMD (NSPR) Tops Q2 EPS by 1c